Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. - Wikidata - wikimedia - TriplyDB

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

http://www.wikidata.org/entity/Q35594697

about

Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma Current Status of Hepatic Arterial Infusion Chemotherapy The role of interventional radiology in the management of hepatocellular carcinoma Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression Staging of hepatocellular carcinoma Management strategies for hepatocellular carcinoma: old certainties and new realities.Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.Reassessing hepatocellular carcinoma staging in a changing patient population.Staging of biliary tract and primary liver tumors.Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease.I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.Staging classifications for hepatocellular carcinoma.Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinoma Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience Surgical treatment for liver cancer. Current issues.Review of current staging systems for hepatocellular carcinoma.Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.Staging systems: Is there a surgical staging and a medical one? A surgeon's perspective.Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.Hepatocellular carcinoma: MR staging and therapeutic decisions.What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).Staging systems of hepatocellular carcinoma: a review of literature.Staging systems for hepatocellular carcinoma: Current status and future perspectives Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.

P2860

Q24186130-56B35EC9-7CA3-41FC-B668-35CDF2FAB294 Q24194017-25032993-75D5-4CE7-9EF3-F39208886120 Q26775437-B088783D-85FC-4404-AFAF-6A56AE528482 Q26996805-74BDCD6E-7DA2-41F0-8BFE-A983EEAF14BB Q27485914-EF34DC08-06FF-45C4-A67E-D59657A94F11 Q28081265-9BC981C9-E82A-4BF7-9A4C-91E3C85BE75B Q30252143-7380ADEE-8752-4A1D-A143-691117A1F715 Q33718951-4E537E4E-F6A3-4A97-BEE9-03F3D1087BB7 Q33767286-E71E1174-3A00-4602-874B-36B7B6BE1D02 Q33773415-72ACA379-BF5C-4BFA-B6A0-137152FA179D Q33787850-E8081EC5-FB0E-4F16-9B79-5166A741B5DE Q34155198-E03EA80D-0511-4546-BB81-F514CB6C38E3 Q34446810-9D83DC75-5494-44AC-8A64-C2E38ADDD8E3 Q34494749-A0C16D2F-84A7-457D-802A-A99864E692D2 Q34733478-3D460FBD-18C4-4494-BBA5-880D33E516BA Q34991643-F5323D0C-FCE0-41E6-85DE-54E3E21FC914 Q35113002-AA7444CB-B708-41C6-A989-007194725B8F Q35200244-0734E681-89A6-4DAE-873B-3B476A0509A0 Q35208826-3BA482A1-EEF7-44AA-B835-7678DA29C65F Q35431693-00BB805C-4DB9-499A-ADD2-AB4D22E38E43 Q35435112-A9F06DBF-18E2-46DC-8A75-BB588B40E7AB Q35597241-BAC49BF7-A9E2-4BD3-B797-A1C6AECD9AAE Q35875277-A863D987-23EA-4139-A7AE-A68ABB98F57F Q36150362-FC3E394F-D507-4D51-80E8-1FDDC2A31E1F Q36582556-FB25A722-58ED-42DD-A96B-71A32449BDDF Q36741673-34780F5B-00EC-47EA-B7D7-FA2D94AEF113 Q36796770-2A858137-A1D0-47DA-97E0-47CFE05AA7E8 Q36945069-7689B033-1BB2-4438-A541-1423AE366E76 Q37068256-3B603452-B8B0-4EC4-889F-2DE65361CFA0 Q37269624-C95185E7-26A7-4C73-9AE8-FB9288EEC679 Q37396794-901EB839-52FE-4A48-98DF-8E121DC33097 Q37614595-BF7D5DCC-DE01-4F36-BC5C-FE8CCDAC725B Q37625925-038D6C00-4564-4E83-9850-6BDA6D8658F0 Q37798839-D08E5CDC-AB26-4466-AAAE-BE835511FEAA Q37863539-24A3AA40-9756-4B2E-88BB-9D7AC9E6FC62 Q37886890-3F2BEEA3-2024-4174-81D7-DBF0B650CCAA Q38022245-0DE2D33E-E9BF-4927-B0CA-5B361D9F917E Q38207014-A29533AB-C012-4E98-8FC4-CFBC29A96712 Q38408876-9EA1318C-C211-420D-B5D7-2C034BBF9846 Q39349696-E346C802-CB38-486F-9A0F-BE3D08FD7AA0

P2860

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

http://www.wikidata.org/entity/Q35594697

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@ast

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@en

type

label

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@ast

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@en

prefLabel

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@ast

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@en

P1433

Q35594697-44AA2576-68CE-4CF1-8911-D573379508E6

P1476

Q35594697-80027CB2-AB93-4CA0-B17C-632974C84B96

P2093

Q35594697-8FF7192C-CB05-4681-9267-962A2D176D3B

Q35594697-D32C658C-4182-4165-8D6C-6CA29B6E13DF

Q35594697-D97787F7-5775-4C30-AC68-33745C37AC76

P2860

Q35594697-00EBE8B2-06D5-48C7-ABCA-88B95DD242C2

Q35594697-5533700A-9BA3-43FE-B075-C9AAA40CDAE0

Q35594697-6ABF1F97-F827-4071-A2FB-E6B25B11AA6E

Q35594697-6F174B7D-2358-4354-A9B3-80E7E807A460

Q35594697-876DCCAC-0106-4B1C-BFC4-116217D474D9

Q35594697-A464DC8C-4F8E-4DBD-BE9F-4D5660AE1890

Q35594697-CC2296A7-9DB6-423C-8EEC-7FC096F97DF2

Q35594697-E578E731-5A07-4BAB-96A9-2671E78FBB97

Q35594697-FB286F74-F8C9-4F1A-AFA7-34A645FE432E

P304

Q35594697-D9F1E014-5DA0-488C-9834-88938B277B00

P31

Q35594697-F02BEA1B-7C1F-49E5-89B6-A432E2B8719A

P356

Q35594697-65489B47-5089-463E-9DC0-0DBB8D5A1A9A

P407

Q35594697-FD86E312-BF89-4235-813B-06D900997526

P433

Q35594697-5F27E199-673A-40F6-8164-60A2F0DF26E2

P478

Q35594697-421F2D39-F80B-4DEC-9E7B-1BFA6C2CC701

P577

Q35594697-F2A940D2-21C0-435C-A1C5-D6C687AED62B

P5875

Q35594697-FF41AA79-06DA-4C46-9F15-AF7B4FCBFFD9

P698

Q35594697-9FCB73FB-CE50-4731-9A00-0CD7AE648372

P921

Q35594697-DF7458F0-3D3D-4DE9-A7AA-AAA21FB8349E

Q35594697-FCE18509-C448-4C1C-B118-386F5882B174

P932

Q35594697-6B82E9F4-A333-4D8D-B339-74815D186D6B

P356

P1433

P1476

Staging of hepatocellular carc ...... rt of 257 patients in Toronto.

@en

P2093

I Levy

http://www.w3.org/2001/XMLSchema#string

Liver Cancer Study Group of the University of Toronto

http://www.w3.org/2001/XMLSchema#string

M Sherman

http://www.w3.org/2001/XMLSchema#string

P2860

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Transection of the oesophagus for bleeding oesophageal varices.

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power

P304

881-885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.50.6.881

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11360434

http://www.w3.org/2001/XMLSchema#string

P698

12010894

http://www.w3.org/2001/XMLSchema#string

P921

P932

1773247

http://www.w3.org/2001/XMLSchema#string